Document Details

Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Diffusion Pharmaceuticals Inc. (Charlottesville, VA)
Event Date 3/2/2018
Filing Date 3/5/2018

Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
Download

File Section(s)

  1. FORM 8-K

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.